The type IV intermediate filament, nestin, may be a candidate diagnostic marker for combined hepatocellular–cholangiocarcinoma (cHCC–CCA). Therefore, the significance of nestin as a diagnostic marker for cHCC–CCA categorized by the… Click to show full abstract
The type IV intermediate filament, nestin, may be a candidate diagnostic marker for combined hepatocellular–cholangiocarcinoma (cHCC–CCA). Therefore, the significance of nestin as a diagnostic marker for cHCC–CCA categorized by the World Health Organization (WHO) 2019 classification and its relationship with clinicopathological features were examined in the present study.
               
Click one of the above tabs to view related content.